Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
LCL161
Description:
An orally administered small-molecule drug that mimics SMAC and antagonizes inhibitor-of-apoptosis proteins in cancer research and treatment.
Primary topic:
Cell death mechanisms and regulation (41%)
Related topics:
Cell death mechanisms and regulation (41%),
Multiple Myeloma Research and Treatments (8%)
OpenAlex ID:
keywords/lcl161
Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
2014
·
Jeffrey R. Infante
, E. Claire Dees
, et al.
·
Journal of Clinical Oncology
·
224
PDF
Promises and Challenges of Smac Mimetics as Cancer Therapeutics
2015
·
Simone Fulda
·
Clinical Cancer Research
·
221
IAP antagonists induce anti-tumor immunity in multiple myeloma
2016
·
Marta Chesi
, Noweeda N Mirza
, et al.
·
Nature Medicine
·
181
Molecular Pathways: Targeting Inhibitor of Apoptosis Proteins in Cancer—From Molecular Mechanism to Therapeutic Application
2013
·
Simone Fulda
·
Clinical Cancer Research
·
114
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation
2018
·
Nobumichi Ohoka
, Yoko Morita
, et al.
·
Journal of Biological Chemistry
·
111
PDF
Development of protein degradation inducers of oncogenic BCR ‐ ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
2017
·
Norihito Shibata
, Naoki Miyamoto
, et al.
·
Cancer Science
·
106
PDF
Smac mimetics: implications for enhancement of targeted therapies in leukemia
2010
·
E Weisberg
, A Ray
, et al.
·
Leukemia
·
104
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program
2011
·
Peter J. Houghton
, Min H. Kang
, et al.
·
Pediatric Blood & Cancer
·
96
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
2017
·
Dae-Sun Kim
, Himika Dastidar
, et al.
·
Nature Communications
·
87
PDF
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
2018
·
Aditya Bardia
, Marina Parton
, et al.
·
Journal of Clinical Oncology
·
82
PDF
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
2012
·
Kuen-Feng Chen
, Jing-Ping Lin
, et al.
·
Biochemical Pharmacology
·
70
An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
2020
·
Yung-Chieh Chang
, Chun Hei Antonio Cheung
·
Applied Sciences
·
53
PDF
OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3
2020
·
Boxiang Zhang
, Chengcheng Yang
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
49
PDF
Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
2014
·
Aiping Tian
, George S. Wilson
, et al.
·
Cancer Letters
·
49
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis
2021
·
Naveen Pemmaraju
, Bing Z. Carter
, et al.
·
Blood Advances
·
46
Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein
2013
·
Qin Qin
, Yun Zuo
, et al.
·
Tumor Biology
·
46
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity
2012
·
Z Yuan
, G Syrkin
, et al.
·
Cancer Gene Therapy
·
43
PDF
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model
2016
·
Christine C. Dobson
, Thet Naing
, et al.
·
Oncotarget
·
42
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist
2023
·
Parima Udompholkul
, Ana Garza-Granados
, et al.
·
Journal of Medicinal Chemistry
·
40
PDF
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
2019
·
Tanmay M. Shekhar
, Ingrid J. G. Burvenich
, et al.
·
BMC Cancer
·
38
PDF
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus–negative Head and Neck Squamous Cell Carcinoma
2019
·
Linlin Yang
, Bhavna Kumar
, et al.
·
Molecular Cancer Therapeutics
·
37
Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells
2016
·
Steve Gerges
, Katharina Rohde
, et al.
·
Cancer Letters
·
37
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
2012
·
Ashley J. Knights
, Jitka Fucikova
, et al.
·
Cancer Immunology Immunotherapy
·
37
Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
2018
·
Shawn T. Beug
, Stephanie J. Pichette
, et al.
·
Molecular Therapy — Oncolytics
·
36
PDF
The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells
2020
·
Yung-Chieh Chang
, Sree Karani Kondapuram
, et al.
·
Toxicology and Applied Pharmacology
·
35
Show more works
View as search
Works count:
151
Citation count:
2,811
Year
Topic
Type